#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15652	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2008	769.1	0	.	n	.	0	G1207A	SNP	1207	1207	G	1416	1416	A	886	A,G	839,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15652	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2008	769.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1659	1659	T	824	T,C	758,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15652	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2008	769.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1393	1393	C	899	C,T	837,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29348	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3606	809.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1627	1627	A	968	A	914	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29348	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3606	809.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2261	2261	C	931	C	861	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29348	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3606	809.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2335	2335	A	904	A	860	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29348	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3606	809.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2887	2887	C	923	C,A	883,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2196	folP	852	852	99.77	folP.l15.c4.ctg.1	1487	146.8	0	.	p	.	0	D71H	NONSYN	211	213	GAT	547	549	CAT	190;193;194	C;A;T	177;178;180	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2196	folP	852	852	99.77	folP.l15.c4.ctg.1	1487	146.8	0	.	p	.	0	A204V	NONSYN	610	612	GCA	946	948	GTA	205;205;203	G;T;A	196;195;192	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2196	folP	852	852	99.77	folP.l15.c4.ctg.1	1487	146.8	1	SNP	p	R228S	0	.	.	682	684	CGC	1018	1020	CGC	214;211;213	C;G;C,T	199;198;196,1	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5474	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3380	161.0	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1072	1074	ATA	170;168;172	A;T;A	161;158;163	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5474	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3380	161.0	1	SNP	p	S91F	0	.	.	271	273	TCC	595	597	TCC	179;178;178	T;C,T;C	165;164,1;167	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5474	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3380	161.0	1	SNP	p	D95G	0	.	.	283	285	GAC	607	609	GAC	171;169;172	G;A,G;C	160;156,1;160	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5474	gyrA	2751	2751	99.82	gyrA.l15.c4.ctg.1	3380	161.0	1	SNP	p	D95N	0	.	.	283	285	GAC	607	609	GAC	171;169;172	G;A,G;C	160;156,1;160	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1876	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1385	134.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	980	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1047	92.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5076	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3030	166.9	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1463	1465	GTC	217;214;216	G;T;C	205;200;199	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5076	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3030	166.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1616	1618	GCA	217;218;222	G;C;A	197;187;196	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5076	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3030	166.9	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2099	2101	ATT	211;211;214	A,G;T;T	194,1;197;203	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5076	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3030	166.9	1	SNP	p	D86N	0	.	.	256	258	GAC	569	571	GAC	198;195;193	G,A;A;C	186,1;182;180	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5076	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3030	166.9	1	SNP	p	S87R	0	.	.	259	261	AGT	572	574	AGT	195;196;199	A,C;G;T	178,2;179;183	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5076	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3030	166.9	1	SNP	p	S87W	0	.	.	259	261	AGT	572	574	AGT	195;196;199	A,C;G;T	178,2;179;183	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5076	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3030	166.9	1	SNP	p	S87I	0	.	.	259	261	AGT	572	574	AGT	195;196;199	A,C;G;T	178,2;179;183	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5076	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3030	166.9	1	SNP	p	S88P	0	.	.	262	264	TCC	575	577	TCC	196;197;195	T;C;C	183;183;183	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4656	parE	1986	1986	99.9	parE.l6.c4.ctg.1	2744	168.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1585	1587	GGC	225;224;228	G;G;C,G	212;209;213,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1132	1134	GCA	228;230;229	G;C,T;A	207;204,1;205	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1135	1137	ATC	230;227;228	A,T;T;C	206,1;205;207	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1147	1149	GTG	233;233;231	G;T;G	216;213;215	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1147	1149	GTG	233;233;231	G;T;G	216;213;215	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1651	1653	ACC	206;205;208	A;C;C	180;187;188	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1705	1707	GCG	184;185;186	G;C,G;G	150;144,1;148	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1705	1707	GCG	184;185;186	G;C,G;G	150;144,1;148	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1828	1830	GGC	184;184;183	G;G;C,T	163;162;160,3	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1837	1839	GGC	174;173;173	G,A;G;C	149,3;155;153	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4318	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2261	189.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1855	1857	CCG	149;152;153	C,G;C;G,C	119,1;123;125,1	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6370	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3197	198.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2514	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1883	132.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	525	525	C	193	C	180	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	T18M	NONSYN	52	54	ACG	344	346	ATG	249;248;245	A;T;G	238;236;236	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	719	721	CAA	267;270;272	C,A,G;A;A	245,1,1;252;251	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	E212D	NONSYN	634	636	GAA	926	928	GAT	273;280;283	G;A;T	257;260;261	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	H213G	NONSYN	637	639	CAT	929	931	GGT	284;282;281	G;G;T	260;262;256	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	V215A	NONSYN	643	645	GTT	935	937	GCT	271;268;265	G;C;T	251;248;247	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	S220T	NONSYN	658	660	AGC	950	952	ACT	262;269;267	A;C;T	242;251;250	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1061	1063	ATG	258;262;266	A;T;G	242;243;244	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1064	1066	AGC	265;268;265	A;G;C	240;246;239	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1067	1069	GGT	262;263;266	G;G;T	241;242;244	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1181	1183	AAC	247;249;249	A;A;C	235;234;234	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3254	porB1b	1047	1047	98.57	porB1b.l15.c4.ctg.1	1483	217.8	1	SNP	p	G120K	0	.	.	358	360	GGC	650	652	GGC	263;258;257	G;G,A;C,G	254;247,1;244,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12084	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4900	245.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2012	2014	CAT	291;291;297	C;A;T	273;271;278	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1334	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1146	115.6	1	SNP	p	V57M	0	.	.	169	171	GTG	586	588	GTG	268;267;269	G;T,C;G,A	251;251,1;253,1	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
